One-year Non-persistence With Contemporary Antiplatelet Therapy in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention
Author:
Publisher
Elsevier BV
Subject
General Medicine
Reference5 articles.
1. Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study;Mehran;Lancet,2013
2. In-hospital switching of oral P2Y12 inhibitor treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention: prevalence, predictors and short-term outcome;Alexopoulos;Am Heart J.,2014
3. Contemporary Use of Ticagrelor in Interventional Practice (from Blue Cross Blue Shield of Michigan Cardiovascular Consortium);Karve;Am J Cardiol.,2015
4. Use of the New Antiplatelet Agents in Acute Coronary Syndromes: Limitations Related to Patient Characteristics;Lozano;Rev Esp Cardiol.,2015
5. Adherence to medication;Osterberg;N Engl J Med.,2005
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Determination of Characteristics and Data Elements Requirements in National Acute Coronary Syndrome Registries for Postdischarge Follow-up;Current Problems in Cardiology;2022-05
2. Trends of Antithrombotic Treatment in Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention: Insights from the GReek-AntiPlatElet Atrial Fibrillation (GRAPE-AF) Registry;Cardiovascular Drugs and Therapy;2020-10-09
3. Consequences of escalation and de-escalation of double antiplatelet therapy in patients with acute coronary syndrome in real clinical practice;Russian Journal of Cardiology;2019-04-13
4. De-Escalation of Treatment With Oral P2Y12 Receptor Inhibitors: Current Status and Perspectives;Journal of Cardiovascular Pharmacology and Therapeutics;2019-02-05
5. Comentarios a la actualización ESC 2017 sobre el tratamiento antiagregante plaquetario doble en la enfermedad coronaria;Revista Española de Cardiología;2018-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3